There's a conversation happening in boardrooms across PE-backed healthcare that nobody's putting on paper.
The pipeline is bigger than it's ever been. The teams running it haven't grown.
From what I've seen across the deals I've worked on and the conversations I'm having now, most corporate development teams at healthcare platforms are evaluating 3-5x the volume of targets they were looking at three years ago. The mandate from the PE holdco is clear: accelerate. Find more. Close faster.
But the team is still 2-3 people. Maybe 4 if you're lucky.